Users

HoloMonitor in use at end user sites

AUSTRALIA

Griffith University
Woolcock Institute of Medical Research
QIMR Berghofer Medical Research Institute
Queensland Centre for Drug Target Screening and Characterisation, Queensland University of Technology
 

CHINA

Institute of Radioactive Medicine, Peking Union Medical College
Institute of Materia Medica, Peking Union Medical College
State Key Laboratory of Tribology, Tsinghua University
School of Chemical Engineering, Tsinghua University
Institute of Biophysics, Chinese Academy of Sciences
Life Science Institute, China Agricultural University
College of Public Health, Hebei Medical University
Nanjing University of Chinese Medicine
Brain Research Center, Tianjin Hospital
Medical School of Shandong University
Sichuan Provincial People’s Hospital
Northeast Agricultural University
Guangdong Medical College
Qiqihar Medical University
Yongchuan Hospital
Qinghai University
Henan University
 

CZECH REPUBLIC

Faculty of Medicine and Dentistry, Palacký University Olomouc
 

FRANCE

National Institute of Applied Sciences, Lyon
Department of Biology, University of Le Havre
IMS Laboratory, University of Bordeaux, 2 units
 

GERMANY

Department Physiology and Pathology of Ion Transport, Leibniz-Institut für Molekulare Pharmakologie
Department of Optical Nanoscopy, German Cancer Research Center (DKFZ)
Light Microscopy Facility, German Cancer Research Center (DKFZ)
Institute for Physiology, University of Regensburg
Clinic for Opthalmology, Hannover Medical School
Bioimaging Center, University of Konstanz
 

AUSTRALIA

Griffith University
Woolcock Institute of Medical Research
QIMR Berghofer Medical Research Institute
Queensland Centre for Drug Target Screening and Characterisation, Queensland University of Technology
 

CHINA

Institute of Radioactive Medicine, Peking Union Medical College
Institute of Materia Medica, Peking Union Medical College
State Key Laboratory of Tribology, Tsinghua University
School of Chemical Engineering, Tsinghua University
Institute of Biophysics, Chinese Academy of Sciences
Life Science Institute, China Agricultural University
College of Public Health, Hebei Medical University
Nanjing University of Chinese Medicine
Brain Research Center, Tianjin Hospital
Medical School of Shandong University
Sichuan Provincial People’s Hospital
Northeast Agricultural University
Guangdong Medical College
Qiqihar Medical University
Yongchuan Hospital
Qinghai University
Henan University
HoloMonitor image of anti­body-targeted T leukemia cells.
Zahra El-Schich, Malmö University
 

CZECH REPUBLIC

Faculty of Medicine and Dentistry, Palacký University Olomouc
 

FRANCE

National Institute of Applied Sciences, Lyon
Department of Biology, University of Le Havre
IMS Laboratory, University of Bordeaux, 2 units
 

GERMANY

Department Physiology and Pathology of Ion Transport, Leibniz-Institut für Molekulare Pharmakologie
Department of Optical Nanoscopy, German Cancer Research Center (DKFZ)
Light Microscopy Facility, German Cancer Research Center (DKFZ)
Institute for Physiology, University of Regensburg
Clinic for Opthalmology, Hannover Medical School
Bioimaging Center, University of Konstanz
3D HoloMonitor images of the preosteoblast cells on nanotube coating and cross section images of typical cells in the beginning and after 24 h.
Beatrix Peter, University of Pannonia
 

HUNGARY

Avidin Biotechnology
The Research Institute of Technical Physics and Materials Science
 

IRAN

University of Tehran, 2 units
 

ISRAEL

Ben-Gurion University of the Negev
Israel Institute for Biological Research (IIBR), 2 units
Sheba Medical Center
 

ITALY

The Biophysics Institute (IBF), Genoa
 

JAPAN

Kindai University
School of Medicine, Kyushu University, 3 units
Biological Function and Engineering, Kyushu Institute of Technology
Department of Molecular Cenetics Division of Cancer Genetics, Kobe University
Center for Stem Cell Biology and Regenerative Medicine, University of Tokyo
Center for Antibody and Vaccine Therapy, University of Tokyo
 

KOREA

Chemical Biology Research Center, Korea Research Inst. of Bioscience and Biotechnology (KRIBB), 2 units
Samsung General Hospital
 

MALAYSIA

Institute for Research in Molecular Medicine, Universiti Sains Malaysia, 2 units
 

POLAND

Aztar Sp.z.o.o.
Histology and Embryology, Medical University of Warsaw
Department of Transplantation, Jagiellonian University, Kraków
 

RUSSIA

InnovaBio
 

SINGAPORE

Esco Micro Pte. Ltd.
 

SWEDEN

Health and Society, Malmö University, 5 units
Cell and Molecular Biology, Karolinska Institutet
Clinical and Experimental Medicine, Linköping University
Microbiology, Immunology and Glycobiology, Lund University
Division of Solid State Physics, Lund University, 2 units
Department of Molecular Biology, Umeå University
Department of Biology, Lund University, 2 units
Biomedical Engineering, Lund University
Laboratory Medicine, Lund Universit
 

SWITZERLAND

Major pharmaceutical company, 3 units
 

TAIWAN

Graduate Institute of Basic Medicine, Fu Jen Catholic University
Institute of Biomedical Sciences
Taipei Veterans General Hospital
Chang Gung University
 

TURKEY

Dep. of Biochemistry, Dumlupınar University
Dep. of Biochemistry, Ege University
Faculty of Pharmacy, Gazi University
 

UK

Translational Health Sciences, University of Bristol
Institute of Medical Sciences, University of Aberdeen
MRC Centre for Regenerative Medicine, University of Edinburgh
 

USA

Department of Dermatology, University of California, San Francisco, 2 units
Department of Ophthalmology and Visual Sciences, University of Iowa
Cell Biology and Human Anatomy, University of California, Davis
Pharmaceutical Sciences, Northeastern University, 2 units
Vascular Biology Program, Boston Children’s Hospital
Molecular and Cellular Biology, Harvard University

Design by Clavis Communications